SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-21-000016
Filing Date
2021-05-05
Accepted
2021-05-05 06:10:39
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20210331.htm   iXBRL 10-Q 1695983
2 EX-31.1 uthrex31103312021.htm EX-31.1 11818
3 EX-31.2 uthrex31203312021.htm EX-31.2 11815
4 EX-32.1 uthrex32103312021.htm EX-32.1 6621
5 EX-32.2 uthrex32203312021.htm EX-32.2 6739
  Complete submission text file 0001082554-21-000016.txt   7757165

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20210331.xsd EX-101.SCH 52930
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20210331_cal.xml EX-101.CAL 81683
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20210331_def.xml EX-101.DEF 307106
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20210331_lab.xml EX-101.LAB 680582
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20210331_pre.xml EX-101.PRE 437461
11 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20210331_htm.xml XML 1328950
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 21891036
SIC: 2834 Pharmaceutical Preparations